DE69715218T2 - Substituierte imidazoliunsalze und deren verwendung zur hemmung der proteinalterung - Google Patents

Substituierte imidazoliunsalze und deren verwendung zur hemmung der proteinalterung

Info

Publication number
DE69715218T2
DE69715218T2 DE69715218T DE69715218T DE69715218T2 DE 69715218 T2 DE69715218 T2 DE 69715218T2 DE 69715218 T DE69715218 T DE 69715218T DE 69715218 T DE69715218 T DE 69715218T DE 69715218 T2 DE69715218 T2 DE 69715218T2
Authority
DE
Germany
Prior art keywords
imidazolic
salts
substituted
inhibit protein
inhibiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69715218T
Other languages
English (en)
Other versions
DE69715218D1 (de
Inventor
R Wagle
San-Bao Hwang
M Mallon
Sara Vasan
John J Egan
Peter Ulrich
Anthony Cerami
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synvista Therapeutics Inc
Original Assignee
Alteon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alteon Inc filed Critical Alteon Inc
Publication of DE69715218D1 publication Critical patent/DE69715218D1/de
Application granted granted Critical
Publication of DE69715218T2 publication Critical patent/DE69715218T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/34Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
    • A23L3/3454Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
    • A23L3/3463Organic compounds; Microorganisms; Enzymes
    • A23L3/3526Organic compounds containing nitrogen
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/34Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
    • A23L3/3454Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
    • A23L3/3463Organic compounds; Microorganisms; Enzymes
    • A23L3/3544Organic compounds containing hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69715218T 1996-05-08 1997-05-02 Substituierte imidazoliunsalze und deren verwendung zur hemmung der proteinalterung Expired - Fee Related DE69715218T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64328896A 1996-05-08 1996-05-08
US84877697A 1997-05-01 1997-05-01
PCT/US1997/007466 WO1997042175A1 (en) 1996-05-08 1997-05-02 Substituted imidazolium salts and their use for the inhibition of protein ageing

Publications (2)

Publication Number Publication Date
DE69715218D1 DE69715218D1 (de) 2002-10-10
DE69715218T2 true DE69715218T2 (de) 2003-03-06

Family

ID=27094226

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69715218T Expired - Fee Related DE69715218T2 (de) 1996-05-08 1997-05-02 Substituierte imidazoliunsalze und deren verwendung zur hemmung der proteinalterung

Country Status (8)

Country Link
EP (2) EP1213282A1 (de)
JP (1) JP2002515033A (de)
AT (1) ATE223384T1 (de)
AU (1) AU724319B2 (de)
CA (1) CA2253788A1 (de)
DE (1) DE69715218T2 (de)
ES (1) ES2183171T3 (de)
WO (1) WO1997042175A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100766158B1 (ko) * 2000-01-19 2007-10-10 알테온 인크. 티아졸, 이미다졸 및 옥사졸 화합물, 및 단백질 노화와관련된 장애의 치료
EP1353676A4 (de) 2000-12-29 2006-05-31 Alteon Inc Methode zur behandlung von fibrosen oder anderen indikationen
ES2243389T3 (es) * 2001-03-21 2005-12-01 Torrent Pharmaceuticals Ltd Compuestos de piridinio utiles para el tratamiento de enfermedades relacionadas con los age.
FR2984733B1 (fr) * 2011-12-22 2016-09-30 Oreal Association d'un agent nucleophile et d'un agent azote ou phosphore de pka superieur a 11 pour la peau glyquee

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356895A (en) * 1984-03-19 1994-10-18 The Rockefeller University 1,4 piperizino inhibitors of non-enzymatic cross-linking of proteins
US5258381A (en) * 1984-03-19 1993-11-02 The Rockefeller University 2-substituted-2-imidazolines
US4983604A (en) * 1987-11-13 1991-01-08 The Rockefeller University Inhibitors of nonenzymatic cross-linking
US5514676A (en) * 1984-03-19 1996-05-07 The Rockefeller University Amino-benzoic acids and derivatives, and methods of use
US5221683A (en) * 1984-03-19 1993-06-22 The Rockefeller University Diaminopyridine compounds and methods of use
US5358960A (en) * 1984-03-19 1994-10-25 The Rockefeller University Method for inhibiting advanced glycosylation of proteins using aminosubstituted imidazoles

Also Published As

Publication number Publication date
WO1997042175A1 (en) 1997-11-13
EP0920418A1 (de) 1999-06-09
ATE223384T1 (de) 2002-09-15
AU2825897A (en) 1997-11-26
DE69715218D1 (de) 2002-10-10
ES2183171T3 (es) 2003-03-16
CA2253788A1 (en) 1997-11-13
EP0920418B1 (de) 2002-09-04
AU724319B2 (en) 2000-09-14
EP1213282A1 (de) 2002-06-12
JP2002515033A (ja) 2002-05-21

Similar Documents

Publication Publication Date Title
DE69629176D1 (de) Verwendung von thiazoliumverbindungen zum verhindern und umkehren der bildung von endprodukten der fortgeschrittenen glykosylierung
DE69938357D1 (de) Umkehrung der fortgeschrittenen glycosylierungsvernetzungen durch verwendung von heterozyklisch substituierten thiazoliumsalzen
DE3650080D1 (de) Verfahren und Mittel zur Hemmung des Proteinveraltens.
ES2174132T3 (es) N-acil-a,omp-alquil-hidrazino-carboximidamidas.
EP0316852A3 (de) Hemmer von nichtenzymatischer Quervernetzung
CA2128248A1 (en) Amino Acids Useful as Inhibitors of the Advanced Glycosylation of Proteins
DE60008509D1 (de) Neue hemmern von fortgeschrittenen glykosilierung-endprodukten
DE69528761D1 (de) Trimerisierende polypeptide, deren herstellung und verwendung
FI844817L (fi) Dispergeringsmedel foer salthaltiga system.
DE69533987D1 (de) Protein oder polypeptid, verfahren zur seiner herstellung und entsprechende zwischenprodukte
ATE354363T1 (de) Kombination von drei substanzen zur vorbeugung und behandlung von arthritis
DE60004786D1 (de) Verfahren und zusammensetzung zur behandlung von akne
DE69715218T2 (de) Substituierte imidazoliunsalze und deren verwendung zur hemmung der proteinalterung
DE602004032345D1 (de) Reagenzien und verfahren zur bildung von disulfid-bindungen und glykosylierung von proteinen
WO1996021450A3 (en) Bis-[hydrazones]
DE69732857D1 (de) Nukleinsaeuren und proteine der katze fc-epsilon rezeptor alpha-kette und deren verwendungen
ATE231845T1 (de) 1,2,4-triazinderivate zur inhibierung der proteinglycosylierung
DE69940971D1 (de) Verwendung von erythropoietin zur behandlung von primärer hämochromatosen
WO1997042175B1 (en) Substituted imidazolium salts and their use for the inhibition of protein ageing
DE69913565D1 (de) Verwendung einer enzymatischen zusammensetzung und verfahren zur affinage von frischem holz
Custer PARTIAL CHARACTERIZATION OF AN INHIBITOR OF BACTERIAL SPORE OUTGROWTH THAT IS THERMALLY DERIVED FROM NITRITE AND THE FORMATION OF ANALOGOUS INHIBITORS FROM LACTOFERRIN OR TRANSFERRIN FRAGMENTS AND NITRITE.
CY1112104T1 (el) Μεθοδος για την προετοιμασια ενος παρασκευασματος πρωτεϊνης που στεγνωνει με κυλινδρο

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee